COR logo Cencora +
Cencora
+

Cencora Overview

Company: Cencora
CEO: Robert Mauch
Symbol: COR
Exchange: NYSE
Industry: Medical - Distribution
Sector: Healthcare
About

Cencora functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items,luding generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client networkludes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.

Continue reading...

Cencora (COR)

  • Stock Price
  • Volume
301.99 +188.42 +166.51%
Past 5 Years
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • 10Y
  • ALL

Revenue

Cencora annual revenue was $321.33 B in 2025.

Net Income

Cencora annual net income was $1.55 B in 2025.

Employees

Cencora annual employee count was 51,000 in 2025.

Revenue by Segment

Cencora’s revenue by segment: Animal Health: $5.69 B, International Healthcare Solutions: $30.37 B and Pharmaceutical Distribution: $285.29 B in 2025.

Revenue by Region

Cencora’s revenue by region: International Healthcare Solutions: $30.37 B and U.S. Healthcare Solutions: $290.98 B in 2025.

Executive Salary

Robert P. Mauch President and Chief Executive Officer, at Cencora, m...

Revenue per Employee

Cencora revenue per employee was $6.30 M in 2025.

Profit per Employee

Cencora profit per employee was $30.47 K in 2025.

Income Statement

Operating Income

Cencora annual operating income was $2.81 B in 2025.

Research & Development

Cencora annual research & development expense was - in 2025.

Tax Rate (%)

Cencora annual Tax Rate was 31.00% in 2025.

Assets & Liabilities | Cash Flow

Total Assets

Cencora annual total assets was $76.59 B in 2025.

Total Liabilities

Cencora annual total liabilities was $74.84 B in 2025.

Capital Expenditure

Cencora annual capital expenditures was -$667.98 M in 2025.

Ratios

Return on Equity (ROE)

Cencora annual return on equity(ROE) was 88.96% in 2025.

Return on Assets (ROA)

Cencora annual return on assets(ROA) was 2.03% in 2025.

Debt to Equity

Cencora annual debt to equity was 712.71% in 2025.

Profitability

Gross Profit Margin (%)

Cencora annual gross profit margin was 3.27% in 2025.

Operating Income Margin (%)

Cencora annual operating income margin was 0.87% in 2025.

Net Income Margin (%)

Cencora annual net income margin was 0.48% in 2025.

Earning Per Share

Cencora annual earning per share was $8.02 in 2025.

EBITDA

Cencora annual EBITDA was $3.70 B in 2025.

Free Cash Flow (FCF)

Cencora annual free cash flow(FCF) was $3.21 B in 2025.

Valuation

Enterprise value

Cencora annual enterprise value was $63.90 B in 2025.

Enterprise value to Revenue

Cencora annual enterprise value to revenue was 0.20 in 2025.

Enterprise value to EBITDA

Cencora annual enterprise value to EBITDA was 17.26 in 2025.

Competitors’ Revenue

Frequently Asked Questions

Who is the CEO of Cencora?

Robert Mauch is the CEO of Cencora.

What industry and sector is Cencora in?

Cencora operates in the Medical - Distribution industry and the Healthcare sector.

What are Cencora's CIK, SIC, and ISIN codes?

  • CIK (Central Index Key): 0001140859
  • SIC (Standard Industrial Classification):
  • ISIN (International Securities Identification Number): US03073E1055

Sign up for free to view

How many employees does Cencora have?

Cencora has 51,000 employees.

What is the revenue of Cencora?

In fiscal year 2025, Cencora generated a revenue of $321.33 Billion.

What is the net income of Cencora?

In fiscal year 2025, Cencora reported a net income of $1.55 Billion.

What is Cencora's biggest product segment?

Pharmaceutical Distribution is Cencora's biggest product segment, representing 88.78% of its total revenue.

When was Cencora listed on the stock exchange?

Cencora went public on Apr 4, 1995, through its Initial Public Offering (IPO), and it has been 31 years since then.

Sign up for free to view

What is the ticker symbol of Cencora, and where is it listed?

Cencora's ticker symbol is COR, and the company is listed on the NYSE stock market exchange.

What is Cencora's current stock price?

Cencora's current stock price is $301.91 as of Jul 15, 2026.

What is Cencora's market capitalization?

As of , Cencora's market cap is .

What is Cencora's ranking in the world?

Ranked #32among 2,804 companies based on market cap.

Who are the top competitors of Cencora?

Competitors of Cencora include McKesson Corporation and Cardinal Health, and more.

People Also Search For

Submit feedback to Bullfincher